8,603
Total Claims
$1.2M
Drug Cost
596
Beneficiaries
$2,061
Cost/Patient
Peer Comparison vs. 109,535 Physician Assistant providers
+187%
Cost per patient vs peers
$2,061 vs $719 avg
+140%
Brand preference vs peers
16.0% vs 6.7% avg
Brand vs Generic
84% generic
Brand: 1,357 claims · $1.1M
Generic: 7,137 claims · $150K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phosphate | 74 | $104K |
| Semaglutide | 63 | $90K |
| Empagliflozin | 49 | $82K |
| Sitagliptin Phos/Metformin Hcl | 63 | $80K |
| Insulin Glargine,hum.Rec.Anlog | 76 | $78K |
| Apixaban | 48 | $65K |
| Budesonide/Formoterol Fumarate | 80 | $52K |
| Linaclotide | 64 | $48K |
| Tiotropium Bromide | 51 | $47K |
| Insulin Detemir | 36 | $37K |
| Insulin Aspart | 30 | $37K |
| Semaglutide | 16 | $32K |
| Rivaroxaban | 26 | $30K |
| Dulaglutide | 22 | $26K |
| Dapagliflozin Propanediol | 14 | $25K |
Prescribing Profile
Patient Profile
64
Avg Age
55%
Female
1.48
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data